107 related articles for article (PubMed ID: 25177793)
21. Interpreting clinical trials: the 'beautiful' case.
Agewall S; Atar D
Fundam Clin Pharmacol; 2009 Apr; 23(2):261-2. PubMed ID: 19236485
[No Abstract] [Full Text] [Related]
22. Austrian survey of treating heart failure--AUSTRIA.
Fruhwald FM; Rehak P; Maier R; Watzinger N; Wonisch M; Klein W
Eur J Heart Fail; 2004 Dec; 6(7):947-52. PubMed ID: 15556057
[TBL] [Abstract][Full Text] [Related]
23. Ivabradine treatment prevents dobutamine-induced increase in heart rate in patients with acute decompensated heart failure.
Cavusoglu Y; Mert U; Nadir A; Mutlu F; Morrad B; Ulus T
J Cardiovasc Med (Hagerstown); 2015 Sep; 16(9):603-9. PubMed ID: 24922198
[TBL] [Abstract][Full Text] [Related]
24. Sudden cardiac death--the challenge to cardiology.
Kjeldsen K; Atar D; Hallén J; Vardas P; Zannad F; Haunsø S
Fundam Clin Pharmacol; 2010 Oct; 24(5):535-7. PubMed ID: 20854303
[No Abstract] [Full Text] [Related]
25. Ivabradine: from molecular basis to clinical effectiveness.
Riccioni G
Adv Ther; 2010 Mar; 27(3):160-7. PubMed ID: 20419486
[TBL] [Abstract][Full Text] [Related]
26. Heart rate in ischemic heart disease. The innovation of ivabradine: more than pure heart rate reduction.
Rosano GM; Vitale C; Volterrani M
Adv Ther; 2010 Apr; 27(4):202-10. PubMed ID: 20495895
[TBL] [Abstract][Full Text] [Related]
27. The importance of reducing heart rate in cardiovascular diseases: effects of Ivabradine.
Vizzardi E; Bonadei I; D'Aloia A; Del Magro F; Piovanelli B; Bontempi L; Curnis A; Dei Cas L
Minerva Med; 2011 Oct; 102(5):373-9. PubMed ID: 22193347
[TBL] [Abstract][Full Text] [Related]
28. Heart rate distribution and predictors of increased heart rate among French hypertensive patients with stable coronary artery disease. Data from the LHYCORNE cohort.
Lorgis L; Zeller M; Jourdain P; Beaune J; Cambou JP; Vaisse B; Chamontin B; Cottin Y
Arch Cardiovasc Dis; 2009; 102(6-7):541-7. PubMed ID: 19664574
[TBL] [Abstract][Full Text] [Related]
29. [Ivabradine: heart rate reduction in coronary heart disease and chronic heart failure].
Bruhn C
Med Monatsschr Pharm; 2012 Jun; 35(6):202-8. PubMed ID: 22808664
[No Abstract] [Full Text] [Related]
30. Evidence-based use of medications in patients with coronary artery disease in a rural Australian community.
Granmyr J; Ball P; Curran S; Wang L
Aust J Rural Health; 2007 Aug; 15(4):241-6. PubMed ID: 17617087
[TBL] [Abstract][Full Text] [Related]
31. Palliation of heart failure.
Davis MP; Albert NM; Young JB
Am J Hosp Palliat Care; 2005; 22(3):211-22. PubMed ID: 15909784
[TBL] [Abstract][Full Text] [Related]
32. Coronary artery disease prevalence and outcome in patients hospitalized with acute heart failure: an observational report from seven Middle Eastern countries.
Salam AM; Sulaiman K; Al-Zakwani I; Alsheikh-Ali A; Aljaraallah M; Al Faleh H; Elasfar A; Panduranga P; Singh R; Abi Khalil C; Al Suwaidi J
Hosp Pract (1995); 2016 Dec; 44(5):242-251. PubMed ID: 27737597
[TBL] [Abstract][Full Text] [Related]
33. Digitalis therapy for patients in clinical heart failure.
Rahimtoola SH
Circulation; 2004 Jun; 109(24):2942-6. PubMed ID: 15210610
[No Abstract] [Full Text] [Related]
34. [The characteristics of the action of mildronate (dihydrate 3-(2,2,2-trimethylhydrazine)propionate) on the red blood parameters in heart failure].
Sisetskiĭ AP; Artiukh VP; Sakharchuk II; Starodub NF
Eksp Klin Farmakol; 1992; 55(3):20-1. PubMed ID: 1458154
[TBL] [Abstract][Full Text] [Related]
35. Effect of adrenergic blockade on plasma adrenomedullin concentration during static handgrip in patients with heart failure.
Krzemiński K; Nazar K; Cybulski G; Mikulski T
Clin Physiol Funct Imaging; 2006 Nov; 26(6):328-34. PubMed ID: 17042897
[TBL] [Abstract][Full Text] [Related]
36. Drug therapy for congestive heart failure. Appropriate choices can prolong life.
Sorrentino MJ
Postgrad Med; 1997 Jan; 101(1):83-6, 89-90, 93-4. PubMed ID: 9008690
[TBL] [Abstract][Full Text] [Related]
37. [Heart rate: a cardiovascular risk factor that can no longer be ignored].
Palatini P
G Ital Cardiol (Rome); 2006 Feb; 7(2):119-28. PubMed ID: 16532723
[TBL] [Abstract][Full Text] [Related]
38. Safety of ivabradine in patients with coronary artery disease and left ventricular systolic dysfunction (from the BEAUTIFUL Holter Substudy).
Tendera M; Talajic M; Robertson M; Tardif JC; Ferrari R; Ford I; Steg PG; Fox K;
Am J Cardiol; 2011 Mar; 107(6):805-11. PubMed ID: 21247517
[TBL] [Abstract][Full Text] [Related]
39. [Curative effects on standardized management of community patients with coronary heart disease complicated with chronic heart failure].
Sun LN; Wang NF; Zhong YG; Li H; Guo SZ; Zhou ZL; Tong GX; Lin J; Sheng GA; Wang YB; Xu P; Liu Y; Zou JW
Zhonghua Yi Xue Za Zhi; 2013 Aug; 93(30):2341-4. PubMed ID: 24300198
[TBL] [Abstract][Full Text] [Related]
40. Acute heart failure syndromes and coronary perfusion.
Beohar N; Erdogan AK; Lee DC; Sabbah HN; Kern MJ; Teerlink J; Bonow RO; Gheorghiade M
J Am Coll Cardiol; 2008 Jul; 52(1):13-6. PubMed ID: 18582629
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
